| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2000 | CN1049816C Process for preparing stock aqueous suspension of sucralfate |
| 02/29/2000 | USRE36594 Spin trap nitronyl hindered phenols |
| 02/29/2000 | US6031135 Protein kinase-c activity; antitumor agents, antiinflammatory agents, preservatives; treating thrombosis |
| 02/29/2000 | US6031133 Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof |
| 02/29/2000 | US6031114 Process for pyrrolidinyl hydroxamic acid compounds |
| 02/29/2000 | US6031111 Indolin-2-one derivatives |
| 02/29/2000 | US6031103 Process for manufacturing 1-[3-cyclopentyl -2(R)-[1(R)-hydroxycarbamoyl)-2-(3, 4, 4-trimethyl -2, 5-D ioxo-1-imidazolidinyl) ethyl] propionyl] piperidine |
| 02/29/2000 | US6031102 Optically active pyridonecarboxylic acid derivatives |
| 02/29/2000 | US6031099 Piperidine derivates having anxiolytic effect |
| 02/29/2000 | US6031096 Acyclovir diester derivatives |
| 02/29/2000 | US6031093 Solid salts of clavulanic acid |
| 02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
| 02/29/2000 | US6031008 Method for detection of potential co-antioxidants |
| 02/29/2000 | US6031007 A homogenous dental emulsion or microemulsion of local anesthetic in oil form, a surfactant having thermoreversible gelling properties, i.e. thickening when contacting mucous membranes, and water; pathological periodontal pockets; scale |
| 02/29/2000 | US6031006 Method of treating diabetic nephropathy |
| 02/29/2000 | US6031005 Topical treatment of connective tissue disorders and dupuytren's contracture by using a transdermal carrier and a dissolved diphenylalkylamine calcium channel blocker agent, e.g. verapamil |
| 02/29/2000 | US6031004 Metformin (2:1) fumarate and metformin (2:1) succinate; antidiabetic and hypoglycemic agents; improved handling, i.e. lower hygroscopicity, free-flowing, reduced compaction susceptibiity, corrosion resistance; improved taste |
| 02/29/2000 | US6031003 Calcium receptor-active molecules |
| 02/29/2000 | US6031002 Topically applying to a surface of the clitoris a vasodilator, e.g. a prostaglandin, dispersed in a carrier which will cause its retension and absorption; nontoxic; side effect reduction |
| 02/29/2000 | US6031001 Topical treatment of psoriasis by applying to the skin a composition comprising prostalandin a2 or j2, or a derivative or an alkyl or benzyl ester of either; antiproliferative agents |
| 02/29/2000 | US6031000 Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| 02/29/2000 | US6030999 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 02/29/2000 | US6030998 Using a parenteral solution of amiodarone free of any tween surfactant and having a ph of 3.5-4.0 at a concentration of about 10-50 mg/ml; side effect reduction; storage stability; nonsettling |
| 02/29/2000 | US6030995 Amino ceramide-like compounds and therapeutic methods of use |
| 02/29/2000 | US6030994 Substituted pyrroles compositions |
| 02/29/2000 | US6030993 2-hydroxypropionic acid derivative and its manufacturing method |
| 02/29/2000 | US6030992 Methods of treating or preventing sleep apnea |
| 02/29/2000 | US6030991 Adjusting the binding of an endothelin peptide to endothelin a or, particularly, endothelin b receptors, i.e. inhibiting or stimulating; antiinflammatory agent; asthma; kidneys; gastrointestinal, cardioascular disorders; hypotensive agents |
| 02/29/2000 | US6030990 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| 02/29/2000 | US6030989 Hemoregulatory compounds |
| 02/29/2000 | US6030988 Immediate release pH-independent solid dosage form of cisapride |
| 02/29/2000 | US6030986 Post-menopausal syndrome, uterine fibroid disease, endometriosis, and aortal smooth muscle cell proliferation; estrogen induced uterine cancer; osteoporosis; restenosis; cardiovascular disorders |
| 02/29/2000 | US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse; |
| 02/29/2000 | US6030983 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 02/29/2000 | US6030981 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 02/29/2000 | US6030980 Agent for the treatment of infections |
| 02/29/2000 | US6030979 Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Quinolizinium derivatives and the salts thereof |
| 02/29/2000 | US6030978 Exhibit fungicidal effect or growth-inhibitory effect against fungi including cutaneous filamentous fungus, such as epidermophyton, microsporum, trichophyton, sporothrix schenckii, aspergillus or candida; nontoxicity; |
| 02/29/2000 | US6030976 Use of sulfonamides |
| 02/29/2000 | US6030975 Carboxylic acid derivatives, their preparation and use in treating cancer |
| 02/29/2000 | US6030974 Topical administration of a long-acting sodium channel blocker, e.g.,tetrodotoxin, saxitoxin; ocular surface anesthesia of long duration without impairing healing; contact lens delivery; excimer laser surgery for myopia |
| 02/29/2000 | US6030972 2- or 5-aminomethyl,2- or 5-cyanopyrimidines as intermediates of anticoagulants in extracorporeal circulation (heart-lung machine, hemodialysis) |
| 02/29/2000 | US6030968 Administering to a mammal an amount of alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid (ampa) receptor allosteric upmodulator; for neurodegeneration without loss of memory or learning; huntington's disease etc.; down syndrome |
| 02/29/2000 | US6030967 And/or like neurotrophic factor (for example, nerve growth factor (ngf), brain-derived neurotrophic factor, neurotrophin-3, and glial cell line-derived neurotrophic factor)-like activity; osteoporosis |
| 02/29/2000 | US6030966 Heterocyclic compound and their use |
| 02/29/2000 | US6030963 For treating neoplastic diseases such as leukemia |
| 02/29/2000 | US6030961 Oxyalkylene phosphate compounds and uses thereof |
| 02/29/2000 | US6030960 Method of treating hepatitis virus infections |
| 02/29/2000 | US6030957 Inhibiting hiv(human immunodeficiency virus) reverse transciptase in cells infected with hiv by administering to infected cells arylphosphate derivative of 2',3'-didehydro-2',3'-dideoxythymidine |
| 02/29/2000 | US6030955 Methods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereof |
| 02/29/2000 | US6030953 For preventing and treating anal leakage of oil in a patient |
| 02/29/2000 | US6030952 As human and veterinary medicine, particularly in the treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmologic conditions, and in cosmetic compositions |
| 02/29/2000 | US6030948 Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
| 02/29/2000 | US6030946 Reversible cysteine protease inhibitors |
| 02/29/2000 | US6030943 Dehydrodidemnin B as an L-type calcium channel enhancer |
| 02/29/2000 | US6030837 Antisense inhibition of PEPCK-mitochondrial expression |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030766 Mixture of n,n'-propylene-dinicotinamide and a liquid carrier; for immersion of extracted organ |
| 02/29/2000 | US6030645 Free-flowing dry particles |
| 02/29/2000 | US6030643 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 02/29/2000 | US6030642 Extended release clonidine formulation (capsule) |
| 02/29/2000 | US6030639 Treatment using prostoglandin and particulate formulations |
| 02/29/2000 | US6030630 Cosmetic compositions for the hair or skin based on sulfone copolyesters with polyorganosiloxane units |
| 02/29/2000 | US6030628 Cosmetic or dermatological preparations containing glycoglycerolipids and their use as surfactants |
| 02/29/2000 | US6030625 Bordetella pertussis and Bordetella parapertussis strains |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030621 Ginkgo biloba composition, method to prepare the same and uses thereof |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030605 Breath freshening compositions and methods using them |
| 02/29/2000 | US6030604 Formulation for inhalation |
| 02/29/2000 | CA2281050A1 Nitric oxide releasing oxindole prodrugs for analgesic, anti-inflammatory and disease-modifying use |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2199613C Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 02/29/2000 | CA2169179C 5-arylindole derivatives |
| 02/29/2000 | CA2155322C Crystalline ceftiofur free acid |
| 02/29/2000 | CA2117349C Benzopyrans and related ltb4 antagonists |
| 02/29/2000 | CA2050072C Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 02/29/2000 | CA2017535C Antispasmodic agents |
| 02/29/2000 | CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/29/2000 | CA2002648C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 02/28/2000 | CA2281442A1 Use of a cationic polymer for the preparation of a complex with nucleic acid and related compositions |
| 02/28/2000 | CA2281055A1 Antithrombin iii-beta-comprising pharmaceutical preparation |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/27/2000 | CA2246027A1 Benzylamidine derivatives with serotonin receptor binding activity |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009672A1 Dnazymes and methods for treating restenosis |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | WO2000009531A2 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009511A1 Novel thiazolopyrimidine compounds |
| 02/24/2000 | WO2000009510A1 Photocyclized rapamycins |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |